IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer. [electronic resource]
Producer: 20151109Description: e104285 p. digitalISSN:- 1932-6203
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- genetics
- Colorectal Neoplasms -- diagnosis
- CpG Islands
- DNA Methylation
- Female
- Humans
- Insulin-Like Growth Factor Binding Protein 3 -- genetics
- Intestinal Mucosa -- metabolism
- Male
- Microsatellite Instability
- Microsatellite Repeats
- Middle Aged
- Mutation
- Neoplasm Staging
- Prognosis
- Promoter Regions, Genetic
- Proto-Oncogene Proteins B-raf -- genetics
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.